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ABSTRACT
Protease inhibitors (PIs) are deployed in the plant kingdom as storage proteins or peptides, regulators of endogenous proteases, and plant 
protection agents against insect pests and pathogen attack. In humans, they are identified as chemopreventive agents against a range of 
cancers and have potential as drug to treat an array of disease associated with aberrant activity of proteases. The present investigation 
reports PIs activity data from 30 medicinal plants. The screening for PIs activity was done by dot blot assay using X-ray film coated with 
gelatin. Among screened seed extracts, Albizia lebbeck, Raphanus sativus, Mucuna pruriens, Achyranthes aspera, and Coffea arabica showed 
high inhibitory activities with trypsin protease. Most of seed extracts exhibited moderate activity, whereas Ocimum sanctum showed 
moderate to low activity against trypsin. The presence of varied protein content is reported from all seed extracts with highest in A. lebbeck 
(50.0 ± 3.4 mg/ml). The data produced in the present investigation could be helpful for further exploration of PIs as therapeutic agent.
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INTRODUCTION
Proteases or peptidases (E.C. 3.4) are one of the largest and the most diverse families of enzymes which selectively catalyze the hydrolysis of peptide bonds in proteins.[1,2] 
Proteases are physiologically vital in all living organisms for 
cell growth, cell differentiation and death (apoptosis), cell 
migration, and invasion and are abundant in a wide variety 
of sources starting from viruses, bacteria, protozoa, metazoan, 
or fungi ending with plants and animals.[3,4] They perform a 
variety of functions during the vital processes in organism 
such as food digestion, blood clotting, embryogenesis, tissue 
reorganization (e.g., wound healing, regeneration, molting, 
metamorphosis, etc.), defense mechanisms, and immune 
responses.[5,6] From the analysis of several genomes, it is 
estimated and found that about 2–4% of all gene products 
are proteases with more than 560 members.[7,8] Proteases 
are intricately involved in the protein catabolism and their 
action can be divided into two different categories: Limited 
proteolysis and unlimited proteolysis. In limited proteolysis, 
proteases cleave specific peptide bonds in immature proteins 
or remove the target signals in pre-proteins, whereas the 
unlimited proteolysis (bulk hydrolysis) of dietary proteins is 
essential for providing cells with simple metabolites essential 
for growth and development. On the basis of catalytic types, 
they can be classified into serine, cysteine, aspartic, threonine, 
glutamic acid, and metalloproteases.[9]
Serine proteases are numerous and widespread among 
the mammals, viruses, insects, bacteria, and eukaryotes, 
suggesting that they are vital to the organisms. Serine 
proteinases are classically categorized by their substrate 
specificity, particularly by whether the residue at P1: trypsin-
like (Lys/Arg preferred at P1), chymotrypsin-like (large 
hydrophobic residues such as Phe/Tyr/Leu at P1), or elastase-
like (small hydrophobic residues such as Ala/Val at P1).[10] 
They are found to be involved in tissue degradation, blood 
coagulation, digestion, development, and immune defense.[11] 
The aberrant activity of these proteases can lead to various 
diseases and thus has been the focus of intense investigation 
as potential therapeutic targets.
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Protease inhibitors (PIs) are molecules that resist 
the proteolytic actions of proteases and play a key role in 
regulation of protein catabolism in the body, the aberrant 
activity of proteases can lead to various diseases and must 
be regulated.[2] The diseases which could be attributed are 
metastasis, angiogenesis, Alzheimer’s disease, Parkinson’s 
disease, AIDS, and ischemia.[12,13] In general, regulation could 
be achieved by differential transcription, post-translational 
processing, subcellular compartmentalization, and the presence 
and activity of PIs.[14,15] The existence of PIs in nature was first 
reported by Fermi and Pernossi.[16] They are small proteins which 
are quite common in nature and also present in all life forms.[17] 
In plants, PIs are generally concentrated (about 10%) in the 
seeds as seed storage proteins.[18] In general, PIs are grouped 
into five groups as serine PIs, cysteine PIs, threonine PIs, 
aspartic PIs, and metalloproteases.[19] Among these, serine PIs 
is predominant followed by cysteine PIs and metalloproteases, 
while aspartic PIs and aspartic PIs are rare and dispersed in 
different families. Serine PIs are widespread, well-characterized, 
and most-studied class of PIs in plants.[20,21] Historically, serine 
PIs were first characterized from soybean plant.[22]
Proteases are proven therapeutic targets and screening 
of potent PIs against aberrant proteolytic activity could lead 
to the development of the drugs. Earlier plant-based PIs 
are found to be effective against cardiovascular diseases, 
osteoporosis, inflammatory diseases, and neurological 
disorders. Several plant PIs are under evaluation in in vitro 
clinical trials for the treatment of many diseases. The PIs have 
widespread applications in different sectors and are one of the 
prime candidates in biotechnology and medicine. The present 
investigation reports the detection and screening of PIs from 
30 medicinal plants.
MATERIALS AND METHODS
Procurement of Seeds
Dry seeds of medicinal plants were purchased from the local 
market of Aurangabad (MS), India.
Procurement of Chemicals
Trypsin (bovine pancreas, E.C. 3.4.21.4), bovine serum albumin 
(BSA), hexane, acetone, and polyvinylpyrrolidone (PVP) 
were obtained from Sisco Research Laboratories, Mumbai, 
India. X-ray films were obtained from Fuji film, USA. All other 
chemicals used in this study were of the highest purity available.
Extractions of PIs from Medicinal Plants
The dried seeds were pulverized to a fine powder in a mixer 
grinder. The fat was removed from the powder by hexane and 
acetone washes. Defatted powder was suspended in Milli-Q 
water (1:6 w/v) containing 1% PVP and incubated overnight 
at 15°C. The suspension was then centrifuged at ×12,000 g for 
20 min at 4°C, and the supernatant was termed as crude PIs.[23]
Detection of PIs by Dot Blot/Spot Test
The dot blot/spot test was carried out to determine the 
potency of PIs against protease trypsin, using X-ray film.[23] 
Three different concentrations of the trypsin and PIs were 
prepared: 1 (1:3), 2 (1:1), and 3 (3:1) v/v. The volume of the 
reaction mixture was adjusted by 0.1 M Tris-HCl (pH 7.8). The 
total volume was made up to 20 µl using buffer and loaded 
onto X-ray film. The film with spots was incubated for 20 min 
at 37°C, then washed with running tap water and dried in air. 
Different ratios of enzyme and inhibitor produced different 
patterns of gelatin hydrolysis on the X-ray film depending on 
the efficiency of inhibitor, which may be observed visually and 
scanned at 300 dpi using an HP digital scanner.
Protein Determinations
Protein content was estimated by following the method of 
Lowry et al.[24] using BSA as the standard.
Statistical Analysis
All experiments were conducted and analyzed in triplicate. The 
means and standard deviations were calculated and compared 
using Microsoft Excel 2010.
Figure 1: Protein content of selected medicinal plants. Values are mean±standard deviation for at least three replicates
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Table 1: Classification and protein content of selected medicinal plants
Botanical name Family Common name Total protein content (mg/ml±SD)
Hygrophila spinosa Acanthaceae Talimkhana 12.8±1.4
Ocimum basilicum Lamiaceae Sweet basil 13.9±1.6
Raphanus sativus Brassicaceae Radish 26.8±1.8
Daucus carota Apiaceae Wild carrot 12.1±1.2
Mucuna pruriens Fabaceae Velvet bean 28.3±1.9
Putranjiva roxburghii Putranjivaceae Putranjiva 12.5±1.4 
Cassia tora Leguminosae Sickle Senna 23.3±1.2
Croton tiglium Euphorbiaceae Jamaal gota 12.0±1.2
Albizia lebbeck Fabaceae Siris tree 50.0±3.4 
Guizojia abyssynica Asteraceae Black seed 13.4±1.5
Gloriosa superba Colchicaceae Flame lily 11.3±1.2
Cucumis melo Cucurbitaceae Muskmelon 14.3±2.3
Plantago ovata Plantaginaceae Ispaghul 13.5±1.5
Eugenia jambolana Myrtaceae Jambolan 32.1±1.8
Mimosa pudica Fabaceae Sensitive Plant 21.1±1.1
Ocimum sanctum Lamiaceae Tulasi 17.1±1.7
Solanum xanthocarpum Solanaceae Kantakari 26.5±2.7
Vitex negundo Lamiaceae Nirgundi 13.1±1.5
Ocimum gratissimum Lamiaceae Ram Tulsi 13.6±2.3
Sida cordifolia Malvaceae Kharinta 19.3±1.3
Celastrus paniculata Celastraceae Malkagani 20.1±1.2
Psoralea corylifolia Fabaceae Bavachi 25.1±2.1
Myristica fragrans Myristicaceae Jatiphala 17.3±1.9
Nigella sativa Ranunculaceae Kalonji 19.1±1.2
Gymnema sylvestre Apocynaceae Gurmar 22.1±2.1
Achyranthes aspera Amaranthaceae Chaff-flower 24.4±2.6
Coffea arabica Rubiaceae Coffee 32.1±2.7
Hemidesmus indicus Apocynaceae Nannari 29.3±1.9
Asparagus racemosus Asparagaceae Shatavari 28.2±2.0
Nelumbium speciosum Nelumbonaceae Lotus/Kamal 37.5±3.2 
SD: Standard deviation
 RESULTS AND DISCUSSION
The past few decades have seen a growing interest in the 
identification, purification, and characterization of novel PIs. 
They are prime candidates who have numerous applications 
in agricultural and medicinal biotechnology. Plants are good 
sources of PIs which protect them against diseases, insects, 
pests, and herbivores.[25] They also explored as natural drugs 
for the treatment of an array of diseases including cancers.[13,26] 
The current study was undertaken to detect the presence of 
PIs activity in seeds of selected medicinal plants. Here, we 
screened about 30 medicinal plants for PIs activity.
The initial experiments were designed to explore total 
protein content from hexane defatted seed powder of these 
plants. The total protein content was estimated by protein 
assay developed by Lowry et al.[24] in terms of BSA equivalence 
[Figure 1 and Table 1]. The protein content was found to be 
higher in medicinal plants belonging to Fabaceae family with 
highest in Albizia lebbeck (50.0 ± 3.4 mg/ml). The higher 
protein content is attributing to the additional nitrogen that 
legumes receive through the process of nitrogen fixation.[27] 
The seed extracts of other medicinal plants were reported to 
have varied protein content as reported in Table 1.
The crude seed extracts of these plants were further 
investigated for PIs activity. The presence of PIs activity was 
confirmed by spot test (dot blot) analysis.[23] Detection of PIs 
was observed by mixing various concentrations of protease 
and inhibitor and spotted on the X-ray film, then the clearing 
zone formed due to gelatin hydrolysis by trypsin and a 
reduction in the clearing zone by trypsin incubated with an 
inhibitor was compared. Dot blot method was used to screen 
a large number of PIs. The results of detection of PIs activity 
by dot blot are shown in Figure 2 and results for screening 
of seed sample of 30 plants for inhibition of proteases are 
given in Table 2.
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Among screened samples, A. lebbeck, Raphanus sativus, 
Mucuna pruriens, Achyranthes aspera, and Coffea arabica showed 
high inhibitory activities against trypsin. At all selected ratio 
(1:3, 1:1, and 3:1) of trypsin and the inhibitor, all these samples 
showed inhibition. Most of the screened seed samples such as 
Cucumis melo, Eugenia jambolana, Sida cordifolia, Myristica 
fragrans, Nigella sativa, Gymnema sylvestre, Hemidesmus indicus, 
Asparagus racemosus, and Nelumbium speciosum exhibited 
moderate to high trypsin inhibitory activity, while Ocimum 
sanctum showed moderate to low activity against trypsin. The 
present study revealed that seed extracts of A. lebbeck, R. sativus, 
M. pruriens, A. aspera, and C. arabica were effective in inhibiting 
the trypsin and could be explored as PIs source.
Proteases are enzymes involved in protein digestion. 
These enzymes are omnipresent in plants, animals, and also 
most microorganisms. They are importantly involved in 
health and well-being by performing a pivotal role in survival 
and maintenance of the organism. They constitute about 2% 
of the human genome. The conduct of proteases in spite of 
many advantages has to be closely regulated and controlled to 
avoid the excess activity of these enzymes, as it may possibly 
damage its host organism. This task of controlling is carried 
out by PIs. The PIs have coevolved with proteases, to control 
their destructive nature.[28] Cancer is a collection of over 100 
devastating diseases that share a number of characteristics, a 
primary hallmark of which is out-of-control growth. There is a 
positive correlation between the aggressiveness of a tumor and 
the secretion of various proteases.[29] A number of reviews on 
various aspects of the use of PIs as a mean to combat cancer have 
been published recently. Therefore, the aim of this study was to 
screen Indian medicinal plants for PIs and A. lebbeck, R. sativus, 
M. pruriens, A. aspera, and C. arabica were found to exhibit PIs 
activity. This study could be useful for the identification of PIs, 
designed for therapeutic applications.
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Table 2: Screening of PIs from seeds extract of medicinal plants 
by dot blot method
Botanical name Trypsin
3:1 1:1 1:3
Hygrophila spinosa N N N
Ocimum basilicum N N N
Raphanus sativus P Y Y
Daucus carota N N N
Mucuna pruriens Y Y Y
Putranjiva roxburghii N N N
Cassia tora N N P
Croton tiglium N N N
Albizia lebbeck Y Y Y
Guizojia abyssynica N P P
Gloriosa superba N N P
Cucumis melo P Y Y
Plantago ovata N N N
Eugenia jambolana P P Y
Mimosa pudica N N N
Ocimum sanctum N N P
Solanum xanthocarpum N N P
Vitex negundo N N P
Ocimum gratissimum N N Y
Sida cordifolia N P Y
Celastrus paniculata N N N
Psoralea corylifolia N N N
Myristica fragrans P Y Y
Nigella sativa P P Y
Gymnema sylvestre P P Y
Achyranthes aspera Y Y Y
Coffea arabica Y Y Y
Hemidesmus indicus P P Y
Asparagus racemosus P Y Y
Nelumbium speciosum P Y Y
N: No inhibition, P: Partial inhibition, Y: Total inhibition, PIs: Protease 
inhibitors
Table 2: (Continued)
Botanical name Trypsin
3:1 1:1 1:3
(contd...)
Figure 2: Detection of protease inhibitor (PI) of trypsin by the dot 
blot method. Three different concentrations of enzymes and inhibitors 
(I [3:1], II [1:1], and III [1:3]) were used for screening of PIs. The 
faint green spot (gelatin) indicates total inhibition of enzymes, while 
dark blue spot (gelatin hydrolysis) indicates no inhibition. TI profile 
of Hygrophila spinosa (a), Ocimum sanctum (b), Cucumis melo (c), and 
Albizia lebbeck (d)
a
b
c
d
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